Regulus Therapeutics Inc.
RGLS · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$9,634 | -$12,791 | -$14,062 | -$11,036 |
| Dep. & Amort. | $85 | $87 | -$1,082 | $89 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $2,249 | $2,463 | $2,422 | $1,865 |
| Change in WC | -$3,113 | -$1,219 | $3,357 | -$1,856 |
| Other Non-Cash | -$200 | -$385 | -$84 | -$699 |
| Operating Cash Flow | -$10,613 | -$11,845 | -$9,449 | -$11,637 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $268 | $0 | -$28 | -$83 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$5,328 | $0 |
| Inv. Sales/Matur. | $21,500 | $24,000 | $24,000 | $0 |
| Other Inv. Act. | -$268 | $0 | $0 | $0 |
| Investing Cash Flow | $21,500 | $24,000 | $18,644 | -$83 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $1,377 | $0 | -$551 |
| Stock Issued | $45 | -$93,811 | $56 | -$193 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $92,415 | $0 | $0 |
| Financing Cash Flow | $45 | $0 | $56 | -$744 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $10,932 | $12,155 | $9,251 | -$12,464 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $38,590 | $26,435 | $17,184 | $29,648 |
| End Cash | $49,522 | $38,590 | $26,435 | $17,184 |
| Free Cash Flow | -$10,345 | -$11,845 | -$9,477 | -$11,720 |